Drug Shortage Report for APO-COLESEVELAM
| Report ID | 216646 |
| Drug Identification Number | 02494051 |
| Brand name | APO-COLESEVELAM |
| Common or Proper name | COLESEVELAM |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | COLESEVELAM HYDROCHLORIDE |
| Strength(s) | 625MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 180 BTL |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-16 |
| Estimated end date | 2024-06-28 |
| Actual end date | 2024-06-26 |
| Shortage status | Resolved |
| Updated date | 2025-04-15 |
| Company comments | Product on allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-01-19 | English | Compare |